UBS AM’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$135K Buy
+21,610
New +$163K ﹤0.01% 3136
2022
Q2
– Sell
-1,678
Closed -$155K – 2713
2022
Q1
$155K Hold
1,678
– – ﹤0.01% 2707
2021
Q4
$373K Hold
1,678
– – ﹤0.01% 2634
2021
Q3
$581K Sell
1,678
-111
-6% -$37.6K ﹤0.01% 2434
2021
Q2
$672K Buy
1,789
+249
+16% +$74.8K ﹤0.01% 2415
2021
Q1
$478K Buy
1,540
+413
+37% +$145K ﹤0.01% 2406
2020
Q4
$282K Buy
1,127
+250
+29% +$61.3K ﹤0.01% 2426
2020
Q3
$162K Hold
877
– – ﹤0.01% 2427
2020
Q2
$219K Buy
+877
New +$192K ﹤0.01% 2365

Other funds holding DTIL

UBS AM's DTIL Position: Q3 2026 in Review

UBS AM opened a new position in Precision BioSciences (DTIL) in Q3 2026: 21,610 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #3136 among its holdings. This is a return to the name: UBS AM previously reported a position in DTIL as recently as Q1 2022.

UBS AM first reported a position in DTIL in Q2 2020 and has held it in 9 quarters since. The position peaked at $672K in Q2 2021. 109 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

  • UBS AM held 21,610 shares of Precision BioSciences worth $135K as of Q3 2026.
  • Precision BioSciences was a new UBS AM position in Q3 2026.
  • Precision BioSciences made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3136 holding.
  • UBS AM first reported a position in Precision BioSciences in Q2 2020 and has held it in 9 quarters since.
  • UBS AM's Precision BioSciences position peaked at $672K in Q2 2021.
  • 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.